Stephan Epinette - 24 Feb 2025 Form 3 Insider Report for CONMED Corp (CNMD)

Role
VP GM International
Signature
/s/Thomas Fistek for Stephan Epinette by Power of Attorney
Issuer symbol
CNMD
Transactions as of
24 Feb 2025
Net transactions value
$0
Form type
3
Filing time
15 May 2025, 09:57:36 UTC
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Epinette Stephan VP GM International C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO /s/Thomas Fistek for Stephan Epinette by Power of Attorney 13 May 2025 0001507941

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNMD Common Stock 15,510 24 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNMD Options To Purchase Common Stock 24 Feb 2025 Common Stock 7,500 $96.16 Direct F2
holding CNMD Options To Purchase Common Stock 24 Feb 2025 Common Stock 7,500 $79.95 Direct F2
holding CNMD RSUs (Restricted Stock Units) 24 Feb 2025 Common Stock 1,375 $0.000000 Direct F3
holding CNMD RSUs (Restricted Stock Units) 24 Feb 2025 Common Stock 3,000 $0.000000 Direct F3
holding CNMD RSUs (Restricted Stock Units) 24 Feb 2025 Common Stock 4,500 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stephan Epinette became an officer of CONMED Corporation on February 24, 2025. Exhibit index Power of Attorney (public).
F2 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
F3 Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.